Management of Patients With Factor VIII Inhibitors
- 31 August 1987
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 1 (2) , 123-130
- https://doi.org/10.1016/s0887-7963(87)70012-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- INTRAVENOUS IgG FOR PATIENTS WITH SPONTANEOUS INHIBITOR TO FACTOR VIIIThe Lancet, 1985
- The Role of Prothrombin Complex Concentrates In the Treatment of Hemophiliacs with Factor VIII InhibitorsScandinavian Journal of Haematology, 1984
- Markers for the Factor VIII Antibody Response in Hemophilia AScandinavian Journal of Haematology, 1984
- Suppression of Secondary Antibody Response by Intravenous Immunoglobulin in a Patient with Haemophilia B and AntibodiesScandinavian Journal of Haematology, 1983
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Factor VIII antibodies in rheumatoid arthritis. Effect of cyclophosphamideArchives of internal medicine (1960), 1980
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980
- MASSIVE FACTOR-VIII INFUSION IN HÆMOPHILIAC WITH FACTOR-VIII INHIBITOR, HIGH RESPONDERThe Lancet, 1977
- Prothrombin concentrates in treatment of Christmas disease and allied disordersPublished by American Medical Association (AMA) ,1969
- A Method for the Study of Antihaemophilic Globulin Inhibitors with Reference to Six CasesBritish Journal of Haematology, 1959